Temozolomide, DNA alkylating/methylating chemotherapeutic agent from Abcam

Product Specs
ItemTemozolomide, DNA alkylating/methylating chemotherapeutic agent
CompanyAbcam
Price Supplier Page View Company Product Page
Catalog Numberab141055
Quantity10 mg, 50 mg
Purity0.99
TypeChemical
Molecule NameTemozolomide

Add to Compare List

Abcam

Discovery Drive

Cambridge Biomedical Campus

Cambridge CB2 0AX

United Kingdom

Phone: +44 (0) 1223 696000 (option 1)
+44 (0) 1223 696000 (option 2)
+44 (0) 1223 771600

Company Profile

Website: http://www.abcam.com

(1) Adiponectin facilitates the cell cycle, inhibits cell apoptosis and induces temozolomide resistance in glioblastoma via the Akt/mTOR pathwayOncology lettersMarch 1, 2025Sun P, Liu F, Huo K, Wang J, Cheng Y, Shang S, Ma W, Yu J, Han J.(c-caspase 3), caspase 3 and Bax were evaluated by western blotting. TMZ treatment TMZ (cat. no. ab141055; Abcam) at concentrations of 0.1 and 1.0 mM were cultured with U251 and U87-MG cells, respectively.

(2) SOCS5 contributes to temozolomide resistance in glioblastoma by regulating Bcl-2-mediated autophagyBioengineeredJune 22, 2022Jie Yu, Lin Han, Feng Yang, Mingliang Zhao, Hong Zhou, Linwang Hu96-well pretreated culture plates, according to the manufacturer’s recommendations. TMZ (catalog no. ab141055) was obtained from Abcam (Cambridge, UK), dissolved in dimethyl sulfoxide, and used at a final concentration

Be the First to Write a Review!

Temozolomide, DNA alkylating/methylating chemotherapeutic agent from Abcam

Description

Abcam

Citations (2)

Reviews

Temozolomide, DNA alkylating/methylating chemotherapeutic agent from Abcam

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map